CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans

Immunity

Volumn 16, Issue 6, 2002, Pages 791-802

  Taborda, Carlos P ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; COMPLEMENT RECEPTOR 4; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; IMMUNE SYSTEM; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; YEAST; YEAST CELL;

EID: 0036065586     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00328-X     Document Type: Article

References (45)

1. Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation
2. Immune recognition. A new receptor for β-glucans
3. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection
4. A galactoxylomannan antigen of Cryptococcus neoformans serotype A
5. The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays
6. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release
7. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte β-glucan receptor
8. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals
9. Cryptococcal polysaccharides bind to CD18 on human neutrophils
10. Molecular characterization of a cDNA that encodes six isoforms of a novel murine A kinase anchor protein
11. CR3: A general purpose adhesion-recognition receptor essential for innate immunity
12. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection
13. Antibody interactions with the capsule of Cryptococcus neoformans
14. Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on the cytokine and leukocyte responses
15. Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis
16. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: Recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit
17. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection
18. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism
19. Mouse peritoneal macrophages cultured serum-free deposit complement on IgM-coated sheep erythrocytes in vitro
20. Opsonization and phagocytosis of Cryptococcus neoformans
21. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages
22. Immune response to Cryptococcus neoformans soluble polysaccharide: Immunological unresponsiveness
23. Cryptococcal meningoencephalitis: Intrathecal immunological response
24. Binding of Cryptococcus neoformans to heterologously expressed human complement receptors
25. Biological correlates of capsular (Quellung) reactions of Cryptococcus neoformans
26. Complement depletion in cryptococcal sepsis
27. MH-S, a murine alveolar macrophage cell line: Morphological, cytochemical, and functional characteristics
28. Regulation of Fc mu receptor-mediated functions of resident and provoked peritoneal macrophages
29. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans
30. Protective murine monoclonal antibodies to Cryptococcus neoformans
31. Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans
32. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages
33. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins
34. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion
35. Cellular charge of Cryptococcus neoformans: Contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding
36. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy
37. Natural antibodies and complement link innate and acquired immunity
38. Reticulum cell sarcoma: An effector cell in antibody-dependent cell-mediated immunity
39. Passive and active immunotherapy for experimental pneumococcal pneumonia by polyvalent human immunoglobulin or F(ab')2 fragments administered intranasally
40. The biological properties of immunoglobulin G and its split products
41. Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes
42. Immunoglobulin M efficacy against Cryptococcus neoformans: Mechanism, dose dependence, and prozone-like effects in passive protection experiments
43. IgM-Fc receptor-mediated phagocytosis of rat macrophages
44. IgA and the IgA Fc receptor